Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus,Abcam,AB272504

Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504) is a rabbit polyclonal antibody and is validated for use in ELISA, ICC/IF, IHC-P and WB. Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504) was first used in a scientific publication in 2020 and has been cited over 48 times in peer reviewed journals. It's performance in IHC in human and mouse samples is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504) has high sensitivity and specificity. Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504) has 5 independent reviews from customers. Anti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus (ab272504) specifically detects SARS-CoV-2 Spike Glycoprotein (UniProt ID: P0DTC2; Molecular weight: 140kDa) and is sold in 100 ug selling sizes. Reagent has more than 76 citations. SARS-CoV-2 Spike Glycoprotein antibody is essential for detecting and studying the spike protein, aiding in COVID-19 research, vaccine development and therapeutic studies

Host

Rabbit

Reactivity

SARS-CoV-2

Application

ELISA, WB, ICC/IF, IHC-P

Platform ID

BAB714646214

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-SARS-CoV-2 spike glycoprotein antibody - Coronavirus
Cat. No.AB272504
HostRabbit
IsotypeIgG
ReactivitySARS-CoV-2
ApplicationELISA, WB, ICC/IF, IHC-P
ClonalityPolyclonal
Concentration1 mg/mL Batch dependent concentration
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS
Storage+4°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Spike protein S1. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed : 32142651, PubMed : 32155444, PubMed : 33607086). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed : 34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed : 32075877, PubMed : 32221306). Alternatively, may use NRP1/NRP2 (PubMed : 33082294, PubMed : 33082293) and integrin as entry receptors (PubMed : 35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed : 33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed : 32817270).. Spike protein S2. Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed : 32142651) or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.. Spike protein S2'. Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed : 32703818, PubMed : 34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed : 34561887). Under the current model, the protein has at least three conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes. See full target information S

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.